Array-Based Comparative Genomic Hybridization for the Genomewide Detection of Submicroscopic Chromosomal Abnormalities  by Vissers, Lisenka E.L.M. et al.
Am. J. Hum. Genet. 73:1261–1270, 2003
1261
Array-Based Comparative Genomic Hybridization for the Genomewide
Detection of Submicroscopic Chromosomal Abnormalities
Lisenka E. L. M. Vissers,1 Bert B. A. de Vries,1 Kazutoyo Osoegawa,3 Irene M. Janssen,1
Ton Feuth,1,2 Chik On Choy,3 Huub Straatman,1,2 Walter van der Vliet,1 Erik H. L. P. G. Huys,1
Anke van Rijk,1 Dominique Smeets,1 Conny M. A. van Ravenswaaij-Arts,1 Nine V. Knoers,1
Ineke van der Burgt,1 Pieter J. de Jong,3 Han G. Brunner,1 Ad Geurts van Kessel,1
Eric F. P. M. Schoenmakers,1 and Joris A. Veltman1
Departments of 1Human Genetics and 2Epidemiology and Biostatistics, University Medical Center Nijmegen, Nijmegen, The Netherlands;
and 3BACPAC Resources Center, Children’s Hospital Oakland Research Institute, Oakland, CA
Microdeletions and microduplications, not visible by routine chromosome analysis, are a major cause of human
malformation and mental retardation. Novel high-resolution, whole-genome technologies can improve the diagnostic
detection rate of these small chromosomal abnormalities. Array-based comparative genomic hybridization allows
such a high-resolution screening by hybridizing differentially labeled test and reference DNAs to arrays consisting
of thousands of genomic clones. In this study, we tested the diagnostic capacity of this technology using ∼3,500
flourescent in situ hybridization–verified clones selected to cover the genome with an average of 1 clone per megabase
(Mb). The sensitivity and specificity of the technology were tested in normal-versus-normal control experiments
and through the screening of patients with known microdeletion syndromes. Subsequently, a series of 20 cytoge-
netically normal patients with mental retardation and dysmorphisms suggestive of a chromosomal abnormality
were analyzed. In this series, three microdeletions and two microduplications were identified and validated. Two
of these genomic changes were identified also in one of the parents, indicating that these are large-scale genomic
polymorphisms. Deletions and duplications as small as 1 Mb could be reliably detected by our approach. The
percentage of false-positive results was reduced to a minimum by use of a dye-swap-replicate analysis, all but
eliminating the need for laborious validation experiments and facilitating implementation in a routine diagnostic
setting. This high-resolution assay will facilitate the identification of novel genes involved in human mental retar-
dation and/or malformation syndromes and will provide insight into the flexibility and plasticity of the human
genome.
Introduction
Mental retardation, with or without additional malfor-
mations, occurs in 2%–3% of the general population.
Although a considerable number of cases can be ex-
plained by the presence of gross chromosomal abnor-
malities or other factors, such as metabolic and/or neu-
rological anomalies, the etiology of mental retardation
remains unexplained for ∼50% of patients (Anderson et
al. 1996; de Vries et al. 1997). Submicroscopic, subte-
lomeric chromosome rearrangements contribute signif-
icantly to mental retardation and malformation, com-
prising up to 5% of the previously unexplained cases
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(Flint et al. 1995; Knight et al. 1999; Biesecker 2002;
de Vries et al. 2003). These findings underscore the po-
tential importance of submicroscopic chromosomal
anomalies as a major cause of human mental retardation
and malformation. To routinely detect these changes in
a diagnostic setting, an efficient and robust technology
is needed that screens the entire genome for copy-num-
ber abnormalities with a resolution beyond the level of
a light microscope (5–10 Mb). Array-based comparative
genomic hybridization (arrayCGH) technology mea-
sures submicroscopic DNA copy-number changes and
allows the simultaneous high-resolution mapping of
these changes onto the genome sequence (Solinas-Toldo
et al. 1997; Pinkel et al. 1998; Snijders et al. 2001). We
previously developed an array-based subtelomeric assay
that screens all human subtelomeric regions in a single
hybridization reaction (Veltman et al. 2002). Here we
report the construction and application of a genomewide
microarray for the identification of known and novel
microdeletions and duplications in patients with mental
retardation and malformations.
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Patients and Methods
Patients
Genomic DNAs, isolated from blood lymphocytes of
four cytogenetically normal, healthy individuals (two
males and two females), were used for array validation
and as normal reference DNAs. Additional genomic
DNAs were isolated from three patients with FISH-ver-
ified known microdeletion syndromes (Prader-Willi syn-
drome [PWS; MIM 176270] on chromosome 15q11-
15q12, Smith-Magenis syndrome [SMS; MIM 182290]
on chromosome 17p11.2, and trichorhinophalangeal
syndrome [TRPS; MIM 190350] on chromosome
8q23.1–q24.11), as well as from 20 patients with
mental retardation and additional dysmorphisms of un-
known etiology. The latter patients were all seen by a
clinical geneticist and had undergone extensive diag-
nostic work-up, including routine chromosome analysis
without a diagnosis. They all had a phenotype suggestive
of a chromosomal abnormality, and all scored three points
or higher on the checklist developed by de Vries et al.
(2001). Genomic DNAs from patients and controls were
isolated and purified using a QIAamp kit (Qiagen), ac-
cording to the instructions of the manufacturer.
Array-Based Comparative Genomic Hybridization
Clone Set.—A total of 3,569 well-characterized, col-
ony-purified, and FISH-verified BAC clones were used
for array construction. Most of the BACs were derived
from the RPCI-11 BAC library used as the main inter-
mediate substrate for the sequencing and mapping of the
human genome (Osoegawa et al. 2001). The set includes
∼3,200 clones selected through a collaboration of the
Children’s Hospital Oakland Research Institute, BAC-
PAC Resources Center, and several other groups to cover
the genome with a 1-Mb resolution (Cheung et al. 2001).
Information on this clone set and its availability can be
obtained at the BACPAC Resources Center Web site.
Additional clones were added to the array, resulting in
an even higher-resolution coverage of genomic regions
known to be involved in human malformation and men-
tal retardation, including the subtelomeric regions of all
human chromosomes (77 clones) (Knight et al. 2000)
and regions associated with known microdeletion syn-
dromes (30 clones). Finally, chromosome 12 and chro-
mosome 18 were covered with a higher density through
the addition of clones used in previous studies (Veltman
et al. 2003b; Zafarana et al. 2003).
Array Preparation.—Genomic target DNAs were iso-
lated from 12-ml bacterial cultures using Qiagen R.E.A.L.
Prep 96 BioRobot kits on a Qiagen BioRobot 9600 (Qia-
gen), following the instructions of the manufacturer. De-
generate oligonucleotide-primed (DOP) PCR was per-
formed on isolated DNA from all clones, essentially as
described elsewhere (Telenius et al. 1992), with minor
modifications (Veltman et al. 2002). Taq2000 (Strata-
gene) was used as a thermostable polymerase. DOP-PCR
products were dissolved at a concentration of 1mg/ml in
a 50% DMSO solution and robotically spotted in trip-
licate onto CMT-GAPS coated glass slides (Corning,
UltraGaps) using an OmniGrid 100 arrayer (Genomic
Solutions). The array consisted of 48 subgrids, and rep-
licates were printed in different subgrids across the array.
Labeling and Hybridization.—Labeling and hybridi-
zation were performed essentially as described elsewhere
(Veltman et al. 2002). In brief, genomic DNA was la-
beled by random priming with Cy3-dUTP or Cy5-dUTP
(Amersham Biosciences). Test and reference samples
were mixed with 120 mg Cot-1 DNA (Roche), copre-
cipitated, and resuspended in 130 ml of a hybridization
solution containing 50% formamide, 10% dextran sul-
fate, 2 # SSC, 4% SDS, and 10 mg/ml yeast tRNA (In-
vitrogen). After denaturation of probe and target DNA,
hybridization and posthybridization washing procedures
were performed using a GeneTAC Hybridization Station
(Genomic Solutions), according to the manufacturer’s
instructions. In brief, an 18-h hybridization with active
circulation of the probe was performed, followed by five
posthybridization wash cycles in 50% formamide/2 #
SSC at 45C and five wash cycles in phosphate-buffered
saline at 20C. Slides were dried by centrifugation after
a brief wash in water.
Image Analysis and Processing.—Slides were scanned
and imaged on an Affymetrix 428 scanner (Affymetrix)
using the Affymetrix 428 scanner software package (ver-
sion 1.0). The acquired microarray images were ana-
lyzed using GenePix Pro 4.0 (Axon Instruments), as de-
scribed elsewhere (Veltman et al. 2002). For all further
analyses, the median of the pixel intensities minus the
median local background was used for every spot on the
array (Cy3 and Cy5, calculated separately). Data nor-
malization was performed in the software package SAS
version 8.0 (SAS Institute) for each array subgrid, by
applying Lowess curve fitting with a smoothing factor
of 0.1 to predict the log2-transformed test-over-reference
(T/R) value on the basis of the average logarithmic fluo-
rescent intensities (Cleveland 1979). This smoothing fac-
tor was shown to result in the lowest percentage of false-
positive results while not increasing the amount of
false-negative results in the validation experiments. A
consequence of this smoothing procedure is that the ra-
tios of the clones with a copy-number gain or loss are
closer to the normal range of log2 ratios than in nor-
malization procedures without this smoothing.
Quality Control.—Clones with an SD of the triplicates
10.3 were excluded in individual experiments, as well
as clones with fewer than two replicates remaining after
this analysis. Excluded from all experiments were 63
clones that did not show reliable hybridization results
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in at least four of the five normal-versus-normal control
experiments. Clones that mapped to the sex chromo-
somes ( ) were not analyzed in detail. The arraynp 163
contains a final set of 3,343 autosomal clones with a
coverage of at least 1 clone per Mb. From this final set,
3% of the clones, on average, were excluded per ex-
periment on the basis of the quality criteria.
Thresholds for copy-number gain and loss were de-
termined by examining the results of the control exper-
iments and of previously published work and were set
at log2 T/R values of 0.3 and 0.3, respectively. Exper-
iments were excluded when 15% of the clones showed
intensity ratios outside of these regions. Of the 40 ex-
periments performed in this study, 5 experiments did not
meet these quality criteria. These experiments were suc-
cessfully repeated. The final data set is available as a
downloadable electronic supplement via the online ver-
sion of this article.
Analysis of Replicate Experiments.—In this study, we
performed a dye-swap experiment for each case (patient
or control). For statistical analysis of these two exper-
iments, we developed a two-dimensional assay in the
software package SAS version 8.0 (SAS Institute) in
which reference regions were calculated containing
99.999% of the data points ( ), assumingPp .99999
that the pairs of normalized ratios follow a bivariate
normal distribution (fig. 1B and 1D). Under the as-
sumption of no deleted or duplicated regions, the num-
ber of data points outside the resulting ellipse is expected
to be 1/100,000# the number of clones on the array—
in our case, . Clones repre-1/100,000# 3,343p 0.03
sented by data points outside this reference region in the
scatterplot are candidates for a microduplication or de-
letion event. However, since a dye-swap experiment was
performed for each case, the data points also have to be
located in the correct quadrant of the scatterplot (i.e., a
positive sign for experiment 1 [patient 1 vs. control 1]
and a negative sign for experiment 2 [control 1 vs. pa-
tient 1] indicates a potentially duplicated clone, whereas
a deleted clone shows opposite signs in both experi-
ments). The a priori thresholds for copy-number gain
(log2 T/R value 0.3) or loss (log2 T/R value 0.3) are
therefore integrated into the scatterplot to indicate the
candidate clones for microdeletion or duplication events.
FISH Validation Experiments
FISH validation experiments were performed on met-
aphase spreads prepared from patient-derived lympho-
blast cell lines using routine procedures. Probe labeling,
slide preparation, and hybridization were carried out
essentially as described elsewhere (de Bruijn et al. 2001).
A Zeiss epifluorescence microscope, equipped with ap-
propriate filters, was used for visual examination of the
slides. Digital images were captured using a high-per-
formance cooled CCD camera (Photometrics) coupled
to a Macintosh Quadra 950 computer. The Image FISH
software package (Intergen) was used for analysis of the
FISH images. Inverted images of DAPI-stained slides
were used for chromosome identification.
Results
Validation Experiments
To test the specificity and sensitivity of the whole ge-
nome BAC array, we performed a series of five normal-
versus-normal control hybridizations using four normal
healthy blood donors (including a dye-swap experiment
for each control). Figure 1A shows a representative ge-
nomic profile resulting from such an experiment. Nearly
all clones show log2 intensity ratios in between the a
priori thresholds for copy-number gain (0.3) or loss
(0.3). In the five normal-versus-normal experiments,
an average of six clones (0.18%) passed these thresholds.
Although very low, this level of background noise would
still require a substantial number of FISH experiments
to distinguish true microdeletions and microduplications
from false-positive results. Therefore, the combination
of two experiments (with dye swap) was analyzed for
each control case, using stringent criteria for the presence
of copy-number gain or loss (see the “Patients and Meth-
ods” section and fig. 1B). The added value of combining
data of two separate (T/R) experiments was clearly
shown by the fact that the number of false positives was
reduced to zero in all four cases tested.
Next, we tested the sensitivity of the technology by
hybridizing DNA from three patients with known, FISH-
confirmed microdeletion syndromes (i.e., one patient
with PWS, one patient with SMS, and one patient with
TRPS) to the genomewide array. Similar to the normal-
versus-normal experiments, DNA samples were hybrid-
ized not only against each other but also against one of
the normal controls. Figure 1C shows the result of a
hybridization of DNA from the patient with TRPS
against DNA from the patient with PWS. A total of four
clones, representing 2.7 Mb of consensus genomic se-
quence on 8q23.3-q24.11, showed TRPS-over-PWS in-
tensity ratios below the threshold for copy-number loss,
thus confirming the presence of a deletion of this ge-
nomic region in the TRPS patient. In addition, five
clones, spanning 2.9 Mb of sequence on 15q11.2,
showed log2 intensity ratios above the (reverse) threshold
for copy-number gain, indicating a deletion of this ge-
nomic interval encompassing the genes SNRPN and
UBE3A in the patient with PWS. The combined results
of two experiments involving the patient with PWS are
shown in figure 1D. The five target clones on 15q11.2
are reproducibly deleted in both experiments and fall
outside the bivariate normal distribution reference re-
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Figure 1 ArrayCGH genomic profiles of validation experiments. Arrays contained 3,343 human autosomal clones (indicated by small
circles representing the mean log2-transformed and Lowess-normalized T/R intensity ratios), ordered in A and C from 1pter to 22qter on the
basis of the physical mapping positions obtained from the November 2002 freeze of the UCSC genome browser. In panels A and C, chromosome
boundaries are indicated by vertical lines. Panel A shows the result of a normal-versus-normal hybridization (control 3 vs. control 1). Nearly
all clones fall within the a priori thresholds for copy-number gain (log2 T/R value 0.3) and copy-number loss (log2 T/R value 0.3) indicated
by the horizontal lines. One clone on chromosome 2 shows an intensity ratio outside these thresholds and might represent a false-positive result.
Panel B shows the result of the combined analysis of the two hybridizations performed with control 1 (X-axis: control 1 vs. control 2; Y-axis:
control 3 vs. control 1). The ellipse represents the border of the reference regions containing 99.999% of the data points; the thresholds for
copy-number gain and loss are also integrated into this figure (see the “Patients and Methods” section for details). As can be seen, there is only
one clone outside the reference region; however, this clone does not pass the thresholds for copy-number loss in both experiments and can
therefore be discarded from further analyses. The clone on chromosome 2 that fell outside the threshold for copy-number loss in panel A is
clearly within the normal reference region and can therefore also be discarded for further analyses. Panel C shows the result of the hybridization
of DNA from a patient with TRPS against DNA from a patient with PWS. A total of four clones, spanning 2.7 Mb of genomic sequence on
8q23.3-q24.11, showed log2 TRPS-over-PWS intensity ratios below the threshold for copy-number loss, confirming the presence of a deletion
of this genomic region in the TRPS patient. In addition, five clones, spanning 2.9 Mb of sequence on 15q11.2, show log2 intensity ratios above
the (reverse) threshold for copy-number gain, indicating a deletion of this genomic region in the PWS patient. No clones outside these target
genomic regions show potential false-positive results. The combined results of two experiments involving the PWS patient are shown in panel
D. The five target clones on 15q11.2 are reproducibly deleted in both experiments and fall outside the bivariate normal distribution reference
region ( ) and within the copy-number loss quadrant indicated in the upper left quadrant.Pp .99999
gion ( ) and within the upper left quadrant,Pp .99999
indicating copy-number loss. Detailed analysis of the
DNA from these two patients and the patient with SMS
(containing a deletion of two genomic clones spanning
a 1.5-Mb region on 17p11.2) showed that the target
microdeletion region could be readily identified in each
individual experiment with the target clones present on
the array. Individual hybridizations showed an average
of seven clones (0.21%) with log2 intensity ratios outside
the thresholds for copy-number gain or loss, very similar
to the percentage of false positives obtained in the nor-
mal-versus-normal control experiments described above.
Statistical analysis of the duplicate experiments for each
case failed to reproduce any of these aberrant ratios,
strongly indicating that these were indeed false-positive
results.
In conclusion, the sensitivity to detect submicroscopic
(1.5–2.9 Mb) deletions was reproducibly validated, and
the specificity of the technology was assured by per-
forming two hybridizations for each case and applying
a stringent statistical analysis.
Detection of Novel Deletions and Duplications in
Patients with Unexplained Mental Retardation and
Dysmorphisms
We selected a test series of 20 patients with mental
retardation of unknown etiology to investigate whether
the high-resolution, genomewide, microarray-based,
copy-number screening would allow the identification
of small genomic changes not detectable by routine
karyotyping. In concordance with the validation ex-
periments, each case was hybridized once against a nor-
mal control sample and once against another patient
with a different clinical phenotype. This procedure was
chosen to minimize the costs and, at the same time, the
risks of hybridizing cases with identical genetic abnor-
malities against each other, which would result in mask-
ing of the abnormality. In 7 of the 20 patients, copy-
number alterations were reproducibly detected by
arrayCGH on our genomewide microarray. In five of
these cases, the results could be confirmed by FISH
on metaphase spreads of the patients. These included
three microdeletions and two microduplications (table
1; fig. 2). De novo occurrence was checked by inves-
tigating DNA samples from the parents. As expected,
the microduplications proved difficult to validate by
FISH. We therefore repeated the arrayCGH procedure
in the two cases with microduplications on a small, high-
density array containing only the regions of interest and
confirmed the presence of a microduplication in both
cases (data not shown).
The largest deletion identified in patient 1 was verified
by FISH (fig. 2F) and targeted 17 clones on the array,
spanning a total region of 8.6 Mb on 7q11.21-q11.23.
The karyotype of this case was re-examined because of
the relatively large size of this deletion, but no abnor-
malities were identified. It is interesting that this genomic
region contains the complete common deletion segment
for the Williams-Beuren syndrome (Bayes et al. 2003).
The other deletions and duplications were consider-
ably smaller. In patient 2, the deletion on 2q22.3-q23.2
was encompassed by three clones mapping in a 2-Mb
genomic interval, whereas, in the other three cases, only
one clone was involved, indicating the presence of ab-
normalities !1 Mb in size. In one patient (patient 3) with
a deletion on 1p21, the deletion was identified by FISH
in the father of the patient as well, indicating that this
might be a novel genomic polymorphism. Similarly, the
duplication of a single clone on 2q21.2 in patient 4 was
identified by FISH in the father. Unfortunately, the par-
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Figure 2 Detailed genomic profiles and FISH validation of copy-number abnormalities identified in five cases with unexplained mental
retardation. Panels A–E represent individual profiles of the affected chromosomes for each case, with clones ordered, for each chromosome,
from pter to qter, on the basis of the physical mapping positions obtained from the November 2002 freeze of the UCSC genome browser. The
centromeric region is indicated by a vertical gray dash, the thresholds for copy-number gain (log2T/R value 0.3) and copy-number loss (log2 T/
R value0.3) are indicated by horizontal lines. Panels F–J represent the FISH validation using (one of) the target clone(s) identified by arrayCGH.
Affected chromosomes are indicated by an asterisk (*). Panel A shows the deletion on 7q11 in patient 1, with 14 clones in this region showing
an average log2 intensity ratio of 0.5. FISH validation of this case is shown in the adjacent panel F, in which one of the deleted clones on
7q11 is shown in red and an undeleted control probe is shown in green. Panel B shows the microdeletion on 2q22 in patient 2 with a total of
three clones crossing the threshold for copy-number loss, with FISH validation in the adjacent panel G. Deletion of a single clone on 1p21 is shown
in panel C for patient 3; this clone was confirmed by FISH to be deleted not only in the patient (panel H) but also in the father of the patient.
Copy-number gain detected in a single clone is shown in panels D and E for patients 4 and 5, with FISH confirmation in panels I and J.
ents of patient 5, whose DNA contained a duplication
of a single clone on 6q25.3-q26, were not available for
checking de novo occurrence.
Discussion
ArrayCGH provides a high spatial genomic resolution
and allows a fully automated evaluation of thousands
of genomic loci. Previous applications have been mainly
directed at genomic abnormalities in cancer (Snijders et
al. 2001; Veltman et al. 2003a; Wessendorf et al. 2003).
In this study, we demonstrate the application of
arrayCGH in detecting known and novel submicroscopic
abnormalities. The specificity and sensitivity of this ap-
proach was tested and validated in cytogenetically normal
and healthy individuals, as well as in patients with known
microdeletion syndromes. Deletions and duplications
were detected reliably in a single overnight hybridization
experiment without a priori knowledge of the genomic
region involved. Individual experiments were performed
with a low level of false-positive results that was reduced
further by performing a replicate dye-swap experiment
followed by a thorough statistical analysis. From our
data, we conclude that such replicate experiments are
essential for implementation in a diagnostic setting, since
they considerably reduce the need for laborious confir-
mation experiments while greatly improving the validity
of the results.
Application of this approach in a pilot study of 20
patients with unexplained mental retardation and ad-
ditional malformations resulted in the detection of five
copy-number abnormalities, three deletions, and two
duplications, all beyond the microscopic resolution
(∼10 Mb). The patient with the largest deletion (8.6 Mb
on 7q11.21-q11.23) was a 2-year-old boy (patient 1)
with severe mental retardation, plagio- and microceph-
aly, postnatal growth retardation, facial dysmorphism
(downward-slanting palpebral fissures, periorbital full-
ness, epicanthus and telecanthus, broad mouth with full
lips, and sagging cheeks), short neck, unilateral simian
crease, and a peripheral and valvular pulmonary ste-
nosis. The deletion completely overlaps with the com-
mon 1.6-Mb region deleted in patients with Williams
syndrome (Bayes et al. 2003). Although this boy had
some facial features fitting the diagnosis of Williams
syndrome, his clinical presentation was more severe
than is commonly observed in patients with Williams
syndrome, most notably the severe retardation. More-
over, a pulmonary valve stenosis is less often observed
in this syndrome (Eronen et al. 2003). It seems likely
that the severity of the phenotype is related to the large
size of the deletion, a finding that has also been observed
in four cases with even larger deletions, three of which
also showed characteristics typical of the Williams syn-
drome (Valentine and Sergovich 1977; Frydman et al.
1986; Mizugishi et al. 1998; Wu et al. 1999).
A 2-Mb deletion on 2q22.3-q23.2 was identified in
a 12-year-old girl (patient 2) who had severe mental
retardation, short stature (height 3 SDs below normal),
microcephaly (head circumference 2.5 SDs below nor-
mal), obesitas, facial dysmorphism (coarse facies, up-
ward-slanting palpebral fissures, hypotelorism, abnor-
mally shaped ears, high nasal bridge, small, carp-shaped
mouth with downward-turned corners, narrow, flat pal-
ate, and broad chin), and long, narrow hands with short
digiti V. The deletion was just distal to a more common
deletion on 2q22 and did not include the SIP1 gene,
which is associated with Mowat-Wilson syndrome (Mo-
wat et al. 2003). The clinical presentation of this girl
differs also from the phenotype seen in this relatively
new syndrome. The deletion is de novo, so haploinsuf-
ficiency of one or more genes within the deleted region
could be causative for the phenotype. So far, no obvious
candidate gene appears to be present in this genomic
region.
In a 23-year-old female (patient 3) with moderate
mental retardation, autism, short stature, minor facial
dysmorphism (upward-slanting palpebral fissures, deep-
set eyes, short philtrum), short broad feet, a small ven-
tricular septum defect, and childhood absences, we de-
tected a deletion of a single clone on 1p21. This deletion
was present in her healthy father, as well. Although
familial occurrence of this small deletion (!1 Mb) does
not rule out a causative role, it may very well be a novel
genomic polymorphism. It is known that similar poly-
morphisms (either deletions or duplications) without
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Table 1
Phenotypes and Detected Microdeletions/-duplications
Patient Sex
Age
(years) Degree of MRa Phenotypeb ArrayCGH Result
1 Male 2 Severe Microcephaly, facial dysmorphism,
pulmonary arterial and valve
stenosis
del(7)(q11.21q11.23), 17 clones,
8 Mb, de novo
2 Female 12 Severe Microcephaly, facial dysmorphism,
short stature
del(2)(q22.3q23.2), 3 clones, 2
Mb, de novo
3 Female 23 Moderate Facial dysmorphism, short stature,
ventricular septum defect
del(1)(p21p21), 1 clone, !1 Mb,
also detected in father
4 Male 2 Severe Microcephaly, facial dysmorphism dup(2)(q21.2q21.2), 1 clone, !1
Mb, also detected in father
5 Male 19 Mild Facial dysmorphism, polydactyly,
polycystic kidney (familial)
dup(6)(q25.3q26), 1 clone, !1
Mb, parents not available
a MR p mental retardation.
b Detailed clinical information is given in the text.
any clinical significance are present in the genome,
but, at present, they are underrecognized. Examples
of known normal genomic variations include a 2.5-Mb
duplication of 8p23.1 (Barber et al. 1998; Engelen et
al. 2000) and a number of subtelomeric polymorphisms
(Ballif et al. 2000; Linardopoulou et al. 2001; Der-Sar-
kissian et al. 2002).
It is interesting that two microduplications were also
detected using this comparative microarray technology.
One duplication on 2q21.2 (!1 Mb) occurred in a 2-
year-old boy (patient 4) with severe mental retardation,
microcephaly, and facial dysmorphism (metopic ridge,
synophrys, arched eyebrows, long eyelashes, upward-
slanting palpebral fissures, low-set, posteriorly rotated
malformed ears, and high nasal bridge). This duplica-
tion was detected also in his father, indicating the pres-
ence of another genomic polymorphism. The other du-
plication was found to be present on 6q25.3-q26 (!1
Mb) in a 19-year-old male (patient 5) with mild mental
retardation, postaxial polydactyly of hands and feet,
facial dysmorphism (upward-slanting palpebral fissures,
high, narrow nasal bridge, short philtrum, retrognathia,
and irregular teething), and medullary polycystic kid-
neys. The kidney abnormality was also present in his
two mentally normal sisters. It is interesting to note that,
in a series of 36 patients with a larger duplication, in-
cluding the 6q25.3-q26 region, four cases have been
reported with a polydactyly (Schinzel 2001). Unfortu-
nately, the parents of this patient were unavailable for
checking de novo occurrence. However, a common
copy-number variation affecting a single BAC at 6q26
was recently reported by Albertson and Pinkel (2003).
In this publication, the observed copy-number differ-
ences between individuals were explained by variation
in the length of the apolipoprotein (a) gene, which is
highly polymorphic in the human genome because of
variation in the number of copies of a 5.5-kb sequence
encoding kringle repeats (Kamboh et al. 1991; Lackner
et al. 1993). Indeed, this gene is located within the BAC
affected in this patient (RP11-43B19), and therefore it
is highly likely that this copy-number change also rep-
resents a genomic polymorphism.
The detection of five microdeletions/-duplications in
a series of 20 patients with mental retardation of un-
known etiology in this pilot study underscores the
strength of the arrayCGH technique. It should be men-
tioned that the patients in this study were selected on
the basis of a phenotype suggestive of a chromosomal
abnormality (de Vries et al. 2001). Therefore, this co-
hort may not be representative of the population of
individuals with mental retardation as a whole. Also,
two of the genomic abnormalities were identified in one
of the parents as well, reducing the chance that these
abnormalities are underlying the disorder. On the other
hand, the resolution of the current microarray is, on
average, 1 Mb, and, therefore, cases with more subtle
anomalies may have been missed. To this end, we and
other groups are in the process of constructing microar-
rays completely covering the genome with an average
resolution of ∼50 kb (for more information, see the
BACPAC Resources Center’s Human BAC Minimal Til-
ing Set Web site).
There are three main applications for using arrayCGH
in patients with mental retardation and malformations.
First, it is to be expected that the number of interstitial
microdeletions/-duplications will be comparable or may
even exceed the ∼5% submicroscopic, subtelomeric
rearrangements currently reported among individuals
with mental retardation (de Vries et al. 2003). For this
reason, this 1-Mb–resolution array is currently being
evaluated in a diagnostic setting in our department. Ul-
timately, this array-based copy-number screening may
partially replace karyotyping in this patient group. Sec-
ond, these studies will facilitate the detection of genes
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involved in physical and mental development. Several
such genes have already been identified as a result of
systematic deletion mapping using microscopic chro-
mosomal abnormalities (Romeo et al. 1994; Belloni et
al. 1996; Robinson et al. 2003). The high resolution of
the arrayCGH method allows for rapid and precise map-
ping of candidate genes for specific malformations. Third,
a systematic analysis of genomic polymorphisms will give
more insight into the flexibility and plasticity of the hu-
man genome. This latter may prove to be a fruitful field
of study, given the fact that such large rearrangements
will often involve multiple genes and may therefore serve
as predisposing factors for multifactorial disorders.
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